Jump to content

Helen Boucher

From Wikipedia, the free encyclopedia
Helen Boucher
Boucher in 2023
Dean of the Tufts University School of Medicine
Assumed office
July 1, 2022
PresidentAnthony Monaco
Sunil Kumar
Preceded byHarris Berman
Personal details
Born1964 (age 59–60)
EducationCollege of the Holy Cross (BA)
University of Texas (MD)
Occupation
  • Physician
  • researcher
  • infectious disease expert

Helen Boucher (born 1964) is an American physician and infectiologist who is the dean of the Tufts University School of Medicine and the Chief Academic Officer of Tufts Medicine, the parent health system for Tufts Medical Center in Boston.[1] She is the first woman to serve as the dean of the Tufts University School of Medicine.[2]

Boucher previously served as Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, a Professor of Medicine at Tufts University School of Medicine, and Director of the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance at Tufts.

Education

[edit]

Boucher graduated with an undergraduate degree in English from the College of the Holy Cross in 1986 before earning a Doctor of Medicine (M.D.) in 1993 from the McGovern Medical School (formerly the University of Texas Medical School at Houston) in the Texas Medical Center.[3] From 1993 to 1997, she was a resident at Deaconess Hospital in Boston, Massachusetts, and was the hospital's chief resident in 1996–1997. Boucher then went on a clinical and research fellowship to Beth Israel Deaconess Medical Center, remaining there until 2000.[4]

Career

[edit]

In October 2022, Boucher was named Dean of Tufts University School of Medicine. Boucher had served as the school’s dean ad interim since July 2021, when she was also named chief academic officer for Tufts Medicine, the parent health system for Tufts Medical Center in Boston.

Boucher has worked as a physician in the field of infectious diseases since the mid-1990s.[5] She is a professor at Tufts University[6] and the founding co-director of the Center for Integrated Management of Antimicrobial Resistance along with Ralph Isberg.[7] She has also served as the Director of the Infectious Diseases Fellowship Program at the Tufts Medical Center,[8] and until assuming the deanship at Tufts University School of Medicine was Chief of the Division of Geographic Medicine and Infectious Diseases.[3][9] As a scholar, her research focuses on drug-resistant medical infections.[6] She has also commented on public medical issues in publications including the Washington Post.[10]

Boucher is also a member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria,[11][12] and is an associate editor of Infectious Diseases[13] and a member of the editorial board for Antimicrobial Agents and Chemotherapy.[14] Boucher is also treasurer of the Infectious Diseases Society of America.[15]

Personal life

[edit]

Boucher is married to Norm Boucher, whom she met while they were both undergraduates at the College of the Holy Cross. They have two daughters.[16]

References

[edit]
  1. ^ "Helen Boucher Named Interim Dean at Tufts University School of Medicine". Tufts University School of Medicine. June 16, 2021. Retrieved 27 October 2024.
  2. ^ "A Conversation with Helen Boucher, New Dean of Tufts School of Medicine and Chief Academic Officer of Tufts Medicine | Tufts Now". now.tufts.edu. 2022-10-21. Retrieved 2022-10-21.
  3. ^ a b "Holy Cross to Host Second Annual Women in Science Day | Newsroom | College of the Holy Cross". news.holycross.edu.
  4. ^ "Faculty Profile: Helen Boucher, M.D." Tufts University. 2022. Retrieved 2024-10-26.
  5. ^ EDT, David H. Freedman On 05/15/19 at 7:10 AM (May 15, 2019). "Doctors are running out of effective drugs because of poor financial incentives to develop them". Newsweek.{{cite web}}: CS1 maint: numeric names: authors list (link)
  6. ^ a b Hall, William (April 9, 2018). Superbugs: An Arms Race against Bacteria. Harvard University Press. ISBN 9780674985070 – via Google Books.
  7. ^ "Tufts Medical Center takes on life-threatening superbug infections". March 8, 2019.
  8. ^ National Academy of Sciences, ed. (December 8, 2017). Combating Antimicrobial Resistance: A One Health Approach to a Global Threat: Proceedings of a Workshop. National Academies Press. ISBN 9780309466554 – via Google Books.
  9. ^ "'Superbug' infections are on the rise, a new CDC report says". Pittsburgh Post-Gazette.
  10. ^ "First New Tuberculosis Drug Approved in 50 Years". The Scientist Magazine®.
  11. ^ Turmelle, Luther (December 27, 2019). "Former New Haven drugmaker seeks bankruptcy protection". New Haven Register.
  12. ^ Jacobs, Andrew (December 25, 2019). "Crisis Looms in Antibiotics as Drug Makers Go Bankrupt". The New York Times.
  13. ^ "Medscape Infectious Diseases Editorial Board". www.medscape.com.
  14. ^ Microbiology, American Society for (July 1, 2014). "Editorial Board". Antimicrobial Agents and Chemotherapy. 58 (7): A3. doi:10.1128/AAC.masthead.58-7. PMC 4068516 – via aac.asm.org.
  15. ^ "Board of Directors". www.idsociety.org.
  16. ^ "Helen W. Boucher '86 Is First Woman Elected Chair of the Holy Cross Board of Trustees | Holy Cross Magazine". magazine.holycross.edu. Retrieved 2024-11-21.